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Summary 
Crosslinking mass spectrometry (Crosslinking MS) has substantially matured as a method 
over the last two decades through parallel development in multiple labs, demonstrating its 
applicability for protein structure determination, conformation analysis and mapping protein 
interactions in complex mixtures. Crosslinking MS has become a much-appreciated and 
routinely applied tool especially in structural biology. Therefore, it is timely that the community 
commits to the development of methodological and reporting standards. This white paper 
builds on an open process comprising a number of events at community conferences since 
2015 and identifies aspects of Crosslinking MS for which guidelines should be developed as 
part of a Crosslinking MS standards initiative.  
 
1. Introduction  
Crosslinking for structural analysis goes back at least as far as 1958, when the topology of 
insulin was investigated by help of a crosslinking reagent (Zahn and Meienhofer, 1958). 
Introducing MS for the detection of crosslinks (crosslinking mass spectrometry, here 
abbreviated as Crosslinking MS, but also known as XL-MS, CXMS, or CLMS) led to increased 
accuracy of identifying which pairs of proteins were linked together in heteromeric complexes 
and increased resolution by revealing the identity of the linked residues and thus the 
interaction regions within these proteins. Technical progress, including the wide variety of 
parallel developments, and biological applications have been reviewed extensively in recent 
years (Leitner et al., 2016; O’Reilly and Rappsilber, 2018; Sinz, 2018; Steigenberger et al., 
2020; Yu and Huang, 2018). 
Encouraged by the worldwide Protein Data Bank (wwPDB) Task Force for Integrative/Hybrid 
Methods (Berman et al., 2019; Sali et al., 2015) to provide experimentalists and modellers with 
a stable access point to crosslinking data, a first open gathering on standards in the 
Crosslinking MS field took place at 14th Human Proteome Organization World Congress - 
HUPO 2015 in Vancouver (Canada). This effort was carried forward into an open podium 
discussion at the 5th Symposium on Structural Proteomics in Halle/Saale (Germany) later that 
year. As a result, at the HUPO-Proteomics Standards Initiative (PSI) meeting 2016 in Ghent 
(Belgium), mzIdentML, the proteomics data standard for peptide/protein identification 
information, embraced crosslinking data from version 1.2 (Vizcaíno et al., 2017). Following a 
closed meeting of senior investigators at the 7th Symposium on Structural Proteomics in 
Vienna (Austria), 2017, again an open podium discussion took place at the 8th Symposium on 
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Structural Proteomics in Berlin (Germany), 2018. A first community-wide, comparative 
Crosslinking MS study was published in 2019 (Iacobucci et al., 2019), organised within the 
European Union COST Action BM1403 as an initiative to develop activities in structural 
proteomics at large, which includes Crosslinking MS. Discussions were continued during three 
meetings in 2019: the American Society for Mass Spectrometry (ASMS) Sanibel Conference 
2019 entitled “Chemical Cross-linking and Covalent Labeling: From Proteins to Cellular 
Networks“, the Dagstuhl Seminar 19351 “Computational Proteomics'', and the 18th Human 
Proteome Organization World Congress - HUPO 2019 in Adelaide. These efforts were brought 
together at the 9th Symposium on Structural Proteomics in Göttingen (Germany) later that 
year. A questionnaire on standardisation of Crosslinking MS was circulated among the 
participants of the meeting. Also, a discussion group formed with participation of 20 research 
labs and companies with strong interests in Crosslinking MS and thus strong representation 
of the field that formulated challenges and recommendations for the field. These were publicly 
discussed within the conference at the end of the meeting. The resulting draft document was 
then circulated to participants and additionally to labs in Crosslinking MS that were not 
represented in Göttingen, to provide them with an opportunity to participate. Following the 
discussions at these meetings, this white paper is now supported by about 30 academic 
laboratories and companies engaged in developing, applying and supporting Crosslinking MS 
and thus a substantial fraction of the field.  
 
2. Crosslinking at the interface of proteomics and structural biology 
Definition of Crosslinking MS: Non-covalent interactions or proximities within or between 
biomolecules are covalently fixed for their detection in an otherwise dissociative analytical 
process involving a mass spectrometer.  
 
Crosslinking MS shares some similarities to conventional structural biology techniques, but 
also has some distinct features. For example, structural dynamics in solution is not 
appropriately reflected in static structures obtained by X-ray crystallography. NMR 
spectroscopy and to some extent (cryo-)electron microscopy are able to reveal ensembles of 
conformational states. Crosslinking data also reflect such solution phase dynamics and are 
often able to provide crucial contact information about flexible regions in proteins that remain 
inaccessible to EM or crystallography and are therefore absent in many deposited structures 
and models. Because of this complementarity to established structural methods, Crosslinking 
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MS has gained acceptance in the structural biology community and any efforts towards 
standardisation should also align with best practices in that field. 
Crosslinking MS is most intimately connected to a wide range of applications in structural 
biology, but is at the same time rooted in MS-based proteomics, two fields where substantial 
efforts for standardisation and harmonisation have developed in the last decades (Berman et 
al., 2006; Burley et al., 2017; Deutsch et al., 2017; Lawson et al., 2011; Montelione et al., 
2013; Sali et al., 2015; Schwede et al., 2009; Trewhella et al., 2013, 2017; Vallat et al., 2018). 
However, the primary data output from Crosslinking MS experiments already differs 
substantially from conventional protein identification and quantification workflows in 
proteomics. Instead of identifying single peptide chains that then jointly identify proteins, the 
main types of identifications in Crosslinking MS are pairs of covalently connected, i.e. 
crosslinked peptides, whereby these peptides may originate from the same or two different 
protein(s). These are then combined into sets of crosslinking sites (pairs of crosslinked 
residues) or, for samples of higher complexity, pairs of interacting proteins. Crosslinking 
involves the use of one or more of a large variety of crosslinking reagents, data acquisition 
strategies and data analysis approaches. Inevitably, this diversity will pose particular 
challenges when it comes to standardising workflows and data formats, and for introducing 
reporting guidelines that the community adheres to. 
Any initiative that attempts to establish standards and guidelines in relation to crosslinking 
needs to capture most of today’s diverse crosslinking community. We are in the fortunate 
position to witness the growth of this community and one might broadly define members of the 
crosslinking community as researchers or labs that (a) develop crosslinking chemistries, 
workflows, software etc.; and those that (b) apply crosslinking to address questions in 
structural biology, molecular biology, systems biology and so on. In some cases, the focus of 
research groups in the Crosslinking MS field may of course cover both directions. In addition, 
crosslinking methods are not restricted to the study of protein-protein interactions and protein 
conformations, but may also include interactions with other classes of biomolecules, including 
other biopolymers and small molecules. In fact, also natural processes can lead to crosslinks 
and these products can be analysed by the tools of Crosslinking MS. 
To increase transparency and access to results, the crosslinking community has already 
established some organisational liaisons, including most prominently with proteomics data 
repositories (ProteomeXchange Consortium (PXC) partners (Deutsch et al., 2020), in 
particular PRIDE (Perez-Riverol et al., 2019) and the jPOST (Moriya et al., 2019)), and 
repositories for integrative/hybrid structural biology (particularly PDB-Dev, a prototype 
repository of the wwPDB for integrative structures (Burley et al., 2017; Vallat et al., 2018)). At 
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the moment, these two types of repositories cover different parts of the crosslinking workflow 
and are not yet interconnected. In the following, we will outline the different steps of this 
workflow and how researchers from different communities may benefit from increased 
reliability, transparency and access. 
 
3. The crosslinking experiment: from sample to shared data  
FIGURE 1 outlines the different steps of a crosslinking experiment and highlights specific 
steps of the procedure. For the sake of this discussion, we will assume that independent of 
the sample type and the specific chemistry involved, a protein or protein mixture has been 
crosslinked, subsequently digested into peptides using one or more proteases and the 
resulting peptide mixture has been analysed by liquid chromatography coupled to tandem MS 
(LC-MS/MS). This experimental workflow can deliver (a) sites of crosslinks that may inform 
modelling of a protein or protein complex structure and (b) information on which proteins were 
linked and thus interacting in a possibly highly complex biological mixture. The raw/primary 
data emerging from an LC-MS/MS experiment are considered the starting point of the data 
analysis pipeline. Primary data that is generated in vendor specific formats may first be 
converted into open file formats suitable for database searching (although some programs 
may be able to work with vendor specific formats directly). Either way, a peak list is generated 
that corresponds to the experimentally acquired MS/MS spectra that are searched against a 
protein sequence database of interest. This database may contain anything from a few protein 
sequences of interest up to a whole proteome database. 
Successful matches to the experimental spectra are designated either peptide-spectrum 
matches (PSMs) or crosslink-spectrum matches (CSM, XSM). These matches correspond to 
the (putative) assignment of the sequence of two peptides, connected by a crosslink at defined 
positions within the peptide sequences. This has implications on error handling, as will be 
discussed below. Therefore, the term crosslink-spectrum match might be more suitable. 
CSMs/XSMs may subsequently be collapsed into higher level contact information: peptide 
pairs, residue pairs or protein pairs. It should be noted that Crosslinking MS also has to 
address the protein inference problem of proteomics (Nesvizhskii and Aebersold, 2005; 
Rappsilber and Mann, 2002) due to the existence of multiple proteins with overlapping 
sequences. In addition, as multiple copies of the same protein are present in a sample, 
crosslinks of a protein to itself may be intramolecular or intermolecular. Often one cannot 
distinguish these self-links without dedicated experimental design or additional considerations 
(Lima et al., 2018; Taverner et al., 2002).  
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Identifications at all levels are associated with some error rate. This concerns the identity of 
the peptides (characterised by the false discovery rate, FDR) and the localisation of the 
crosslinking sites (characterised by the false localisation rate, FLR). FDRs can, in principle, 
be determined by so called target/decoy search strategies whereby the MS/MS spectra are 
searched against the target sequence database and a database of non-natural decoy 
sequences that are typically obtained by reversing or shuffling the sequences contained in the 
target database (Fischer and Rappsilber, 2017, 2018; Maiolica et al., 2007; Walzthoeni et al., 
2012). The frequency of matches to the decoy database is then assumed to be equivalent to 
the frequency of random hits to the target database, this correlation is used to calculate the 
FDR. There are several caveats to consider for FDR control in crosslinking: First, the mere 
fact that a combination of two peptides is identified raises the chance for error compared to 
single peptide chain identifications. It suffices if one of the two peptides is false for the whole 
to be false (Trnka et al., 2014). Also, false positives increase proportionally when moving from 
CSM/XSM to peptide pair to protein pair level (Fischer and Rappsilber, 2017). This error 
propagation is a result of the typically observed redundancy of true positive hits (multiple 
CSMs/XSMs per peptide pair, multiple peptide pairs per protein pair) while random false 
positives by definition are less redundant. Therefore, FDRs need to be controlled at multiple 
levels, in the same way as for conventional proteomics experiments when moving from 
CSMs/XSMs to identified peptides and identified proteins. Second, the search space of self 
and heteromeric crosslinks are of different size. Therefore, the error of self and heteromeric 
links must be considered separately (Lenz et al., 2020; Walzthoeni et al., 2012). Third, for 
samples of limited complexity, when using only a small sequence database, and dependent 
on the crosslinking chemistry and data analysis strategy, there may be an insufficient number 
of decoy hits for an accurate determination of FDRs. Most FDR strategies try to model the tail 
of the false positive score distributions, but in a sparse data set this boundary is strongly 
affected by the selection of search parameters such as database composition 
(inclusion/exclusion of contaminant proteins) or the defined specificity of the crosslinking 
reagent. 
Although the field has already seen substantial progress in FDR control, many commonly used 
software tools do not yet support FDR control at all levels, and there is no consensus yet for 
how FDRs should be collected for all experimental designs currently applied in crosslinking 
(Beveridge et al., 2020; Keller et al., 2019a; Yugandhar et al., 2020). Especially when dealing 
with error rates at the crosslinking site level, the FLR (related to the confidence of correctly 
assigning the crosslinked residues within the two peptide sequences) also needs to be taken 
into account. This is an even more challenging problem because precise localisation of the 
crosslink sites requires the observation of not just any fragments of the peptides but those that 
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allow excluding alternative sites. Often, the linkage site is assigned based on the known or 
assumed reactivity of the crosslinker, an approach that fails at least when using photo-
crosslinking (Schneider et al., 2018). Note that crosslinks reveal proximity and it remains to be 
seen what precision is required by modelling. Here, Crosslinking MS may differ from PTM 
mapping, for example, where the exact PTM site can be critical for mechanistic studies. 
Additional challenges arise when chromatographic co-elution of the same peptide pair but 
linked at different sites occurs. 
Eventually, the outcome of crosslinking experiments is made publicly available through 
different channels, mostly journals and data repositories. Research articles provide 
experimental details and mostly qualitative but increasingly also quantitative crosslinking 
results (Chen and Rappsilber, 2018), in widely varying degrees of detail. Crosslinking 
identifications are typically reported in a tabular format in the main manuscript or (more 
commonly) integrated into the online supporting information section as standalone tables or 
formatted in a joint file with other supplementary data, for example in PDF format. Although 
this solution may at least fulfil minimum expectations of data transparency, such a deposition 
complicates data reuse and reanalysis especially as the formatting lacks a common standard 
that specifies what essential data should be included in such a table. Proteomics data 
repositories already offer some support for crosslinking data sets; for example, a project can 
be designated as a crosslinking study in the ProteomeXchange partner repository PRIDE and 
all data necessary for a “complete” submission can be provided. However, the submission is 
labelled as “partial” and therefore does give the false impression of being not entirely adhering 
to open data sharing principles and cannot be cited through a Digital Object Identifier, which 
is increasingly becoming part of open data policies (Gierasch et al., 2020). The PXC partner 
repository jPOST accepts such complete submissions as “complete”, fortunately. Version 1.2 
of the open mzIdentML standard (Vizcaíno et al., 2017) developed by the Proteomics Standard 
Initiative of the Human Proteome Organization and the official PSI validator offer support for 
some crosslinking results (Montecchi-Palazzi et al., 2009), but not all types of workflow are 
supported, for example the increasingly popular cleavable crosslinking reagents are not 
completely covered. The less complex mzTab format would be an alternative output format.  
Apart from the MS-centric data deposition, alternative locations for data integration would be 
resources such as protein sequence databases (e.g. UniProt (UniProt Consortium, 2019)) or 
protein interaction databases such as IntAct (Orchard et al., 2014), STRING (Szklarczyk et 
al., 2019), BioGRID (Oughtred et al., 2019) or ComplexPortal (Meldal et al., 2019). In fact, 
IntAct is already including published crosslinking data on protein-protein interactions, even 
though the Crosslinking MS field has not established appropriate quality control mechanisms. 
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Some crosslinking data are also available through individual lab efforts such as XLinkDB 
(Keller et al., 2019b). In the specific context of the use of crosslinking data for integrative/hybrid 
modelling, the data dictionary (Vallat et al., 2018) used by PDB-Dev already offers support for 
crosslinking site centric distance restraints. However, at the moment there is no interoperability 
between these different resources that would seamlessly connect all these different 
repositories and databases. The following section will explain why this would be highly 
valuable to different audiences. 
 
4. Requirements for maximal impact of Crosslinking MS 
To maximise the use of Crosslinking MS its data should be made available adhering to the 
principles of FAIR (Findable, Accessible, Interoperable, Reusable) (Wilkinson et al., 2016). In 
addition, all of the experimental steps should be transparent to others by providing a sufficient 
amount of information, defined jointly by the community, and by providing this information in a 
suitable format in articles and in data repositories. This has been done for multiple other 
proteomics data types (http://www.psidev.info/miape) (Taylor et al., 2007). However, different 
communities that stand to benefit require different types of data and differ in the level of detail 
required for reuse. This needs to be considered before planning a course of action. 
Peers (wet- and dry-lab scientists working in the crosslinking area) may use data to learn 
about new developments in the field, to assess the validity of published work and to reanalyse 
existing data sets, for example in the context of software development. For these purposes, 
detailed information and access to many different files are required. This includes raw/primary 
MS data and peak lists used for the initial search together with the search configuration and 
database. It also includes “technical” metadata (including details related to the original search 
such as software (version) and search parameters) and details about the instrumentation for 
which already a first example of a reporting template exists (Iacobucci et al., 2019). Finally, 
one also requires identifications at different levels (CSMs/XSMs, peptide pairs, residue/site 
pairs, protein pairs) including decoys, details about the FDR control (what approach was used, 
at which levels was FDR control applied, although this should ideally be standardised), and 
“biological” metadata (related to the nature of the sample and the experimental design, e.g. 
replicates or perturbations and sample treatment) together with the link to a publication if 
applicable. 
Structural, computational or systems biologists are more likely to not work with the raw MS 
data themselves, but they will be rather interested in using the outcome of crosslinking 
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experiments for modelling protein conformations, protein complexes or cellular networks. As 
a consequence, these communities may primarily be interested in the identifications at residue 
level or protein-protein interaction level with associated measures of confidence (FDR) and 
possibly abundance. The chemistry of the crosslinking reagent should be well defined 
regarding reactive sites and spacer length to define appropriate boundaries for crosslink 
restraints. A stable link to the primary data is required, for example in a proteomics repository, 
and the data needs to be provided in standardised form (also a wwPDB Integrative/Hybrid 
Methods Task Force recommendation (Berman et al., 2019; Sali et al., 2015)). The data 
should be findable and experimental details documented, i.e. some basic technical and 
biological metadata need to be associated with the data together with a link to a more detailed 
description, ideally a publication. 
Finally, molecular and cell biologists and other researchers interested in protein interactions 
in general might be interested in crosslinking data because they represent binary interactions 
between proteins and/or specific residues in proteins. For these communities, the biggest 
value will come from access through an intuitive interface, to identifications at residue level or 
protein-protein interaction level with associated measures of confidence (FDR). This might be 
best achieved by the integration of such data into resources (databases) that they normally 
use, such as IntAct, STRING, or UniProt. A useful point of reference would be the HUPO PSI-
MI standard which records molecular interactions without including the supporting MS data. 
These access points may either need to expand their data visualisation to include topological 
information or an additional interface may be needed that provides intuitive access also to 
residue-level information, akin to what is offered by tools such as xVis, xiNET and xiVIEW 
(Combe et al., 2015; Graham et al.; Grimm et al., 2015) or in field databases such as ProXL 
(Riffle et al., 2016). 
In summary, different user bases require a different scope and granularity of the information 
that is obtained from crosslinking experiments. In any case, the ideal scenario would be a 
transparent and seamless flow of information to and from all resources connected to 
crosslinking in standardised formats, raising the question which parts of the workflow can and 
should be standardised. 
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5. Recommendations as to where the Crosslinking MS field requires standardisation 
We feel that the Crosslinking MS field will benefit the most from field-developed standards in 
four specific areas of Crosslinking MS analyses and reporting, leading to the eleven tasks 
summarised in Table 1 and presented in detail below. 
Table 1. Recommendations (single sentence summaries of the field's to-do list) 
1 Define best practices in experimental design for different applications of 
Crosslinking MS. 
2 Find consensus on procedures to reliably assess error rates for all workflow 
types and at different levels (site pair to protein pair). 
3 Ensure support by and complete integration with proteomics data repositories 
such as proteomeXchange. 
4 Develop consistent terminology and common vocabularies for metadata 
annotation of Crosslinking MS data sets. 
5 Provide enhanced support for data sharing with community-agreed file 
formats such as mzIdentML or mzTab. 
6 Define minimal requirements for reporting Crosslinking MS data in peer-
reviewed publications. 
7 Facilitate access to modellers by providing results in formats suitable for 
structure and model repositories such as wwPDB/PDB-Dev. 
8 Develop parsers for data integration in interaction databases and develop 
easily accessible visualisation tools. 
9 Ensure flexibility for new developments in the field, not all steps need to be 
standardised as workflows evolve. 
10 Organise benchmarking studies for objective comparisons of key 
experimental and computational steps. 
11 Establish minimum reporting standards for reporting new or improved 
reagents and software tools. 
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5.1 Workflows / Experiment 
Recommendation 1: Best practice in experimental design 
While there is a large diversity of analytical tools and concepts being utilised in Crosslinking 
MS they are all based on the same principle of preserving structural information by introducing 
artificial covalent bonds in and between biomolecules that would otherwise be lost during the 
mass spectrometric analysis. Therefore guidelines should be developed ensuring that the 
resulting data can conclusively be interpreted. This should address fundamental aspects of 
experimental design such as the number and type of replicates and whether different 
recommendations are required for different types of experiments, e.g. the analysis of highly 
purified, individual proteins or small protein complexes versus whole cell analysis and 
qualitative versus quantitative experiments. This may include control experiments to address 
oligomerization or sample integrity. An appropriate mechanism has to be set up that allows 
identifying where best practice guidelines are needed and then developing these guidelines 
while allowing their continuous adaptation to our progressing understanding of Crosslinking 
MS. 
Recommendation 2: Error assessment 
It is important to determine the error of Crosslinking MS data by a transparent and thoroughly 
tested method. There is currently a large number of methods for FDR control that are usually 
based on the target-decoy approach. Also comparisons are made to available high-resolution 
structures, which has its limitations as this is also experimental data and in addition describes 
a static representation of a protein or protein complex. It is of utmost importance that the field 
arrives at a consensus for procedures that return a reliable error assessment. It is also 
important that the limits of these procedures are mapped out. Future studies hopefully then 
employ this field-agreed error assessment method in its respective current form. This would 
be largely helped by swift integration into the main data analysis workflows by the respective 
developers. Changes of the procedure must be well documented and thoroughly tested before 
coming into effect.  
5.2 Data sharing 
Recommendation 3: Public repositories 
All data of Crosslinking MS should be shared in an open and stable way in a public repository. 
This provides a stable dataset identifier such as an accession number and a defined data 
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structure to cross-reference crosslinking datasets in other resources and requires 
standardised metadata (Recommendation 4) and standardised file formats (Recommendation 
5). This is already the case for proteomics data and there is no need to develop a Crosslinking 
MS specific new repository, although Crosslinking MS specific adaptations of existing 
proteomics repositories are needed. The PRIDE repository, as one of the PXC members, has 
committed to being a partner in this endeavour. Basic functionality for “partial” submissions 
(raw MS data and some metadata) is already available, but should be considered the minimum 
baseline for data sharing. For “complete” submission, some extensions need to be made to 
better address the Crosslinking MS results. Another PXC member, the jPOST repository, has 
already accepted several Crosslinking MS projects with “complete submission”, but will 
continuously need to work with the field to universally address the diverse data modalities of 
Crosslinking MS. Ultimately, the criteria for “complete” submission are Crosslinking MS 
specific and need to be defined by the field. These then must be implemented through basic 
and in the longer term possibly also more elaborate checks during submission, making 
“complete” submissions possible for Crosslinking MS data independent of criteria applied to 
the data of other fields.  
The Crosslinking MS data that enters public repositories should receive a quality check at all 
levels, ideally automatically at the point of uploading. This pertains to the elemental integrity 
of the files, their adherence to the agreed standard formats which includes semantic validation 
and readability by parsers that increase the data availability and reach, and data quality 
metrics such as a measure of confidence. For this, appropriate software will need to be 
developed and maintained in a field effort, in collaboration with data repositories. Results of 
Crosslinking MS that then enter other repositories should do so together with a measure of 
confidence (see Recommendation 8).  
Recommendation 4: Metadata 
All information needed to reproduce Crosslinking MS results must be provided in full. 
Duplications in locations where this takes place should be minimised, though. A minimal set 
of critical information that is required for a basic understanding of the Crosslinking MS results 
should be provided as part of data submission. A standardised description of a crosslinking 
experiment requires the definition of common, controlled vocabularies. XLMOD (Mayer, 2020) 
(https://raw.githubusercontent.com/HUPO-PSI/mzIdentML/master/cv/XLMOD.obo) as an 
effort coordinated via the HUPO PSI regarding controlled vocabularies in crosslinking covers 
“cross-linking reagents, cross-linker related post-translational modifications, and derivatisation 
reagents for GC-MS and LC-MS”. Other terms for a standardised, minimal description of a 
Crosslinking MS experiment will need to be defined in additional efforts. Full experimental 
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details should be provided in the experimental section of publications. A good starting point of 
what should be included here are the recommendations emerging from a first community study 
(Iacobucci et al., 2019). This is currently taking a tabular form as is also practised in other 
fields (Henderson et al., 2012; Masson et al., 2019; Montelione et al., 2013; Read et al., 2011; 
Trewhella et al., 2017). Metadata about instrumentation and data acquisition parameters 
would ideally be parsed from the raw data before submission and written automatically into 
the submitted file. Likewise, search parameters should automatically be documented in a form 
so that users can effortlessly pass them on to the data repository as part of their submission. 
It would be desirable to minimise the number of separate files by combining all relevant 
experimental information possibly together with the results into a single file. 
Recommendation 5: Community-agreed file formats 
All data that is shared should be shared in an open and community-agreed format that is 
extensible to support the evolving needs of the community. This has been successfully 
performed for peak list formats such as mzML. A standard result file format should be 
developed and include a complete list of target and decoy identifications as potential true and 
known noise distributions. Integrative/hybrid modelling is tolerant to substantial error rates and 
including the known noise (decoy matches) allows the modelling field to build ways how to 
deal with noise in crosslinking data into their procedures (Berman et al., 2019; Rout and Sali, 
2019) although the decoy matches form only an initial noise model that is converted into an 
actual noise model by FDR estimation procedures. This format might be based on already 
existing standard formats such as mzIdentML or mzTab, which are supported by the HUPO-
PSI as the initiative in the proteomics field on procedures for standardisation. mzIdentML 1.2 
would be a starting point for further efforts since it already supports some albeit not all types 
of crosslinking data (Vizcaíno et al., 2017). Crosslinking data is currently not supported in 
mzTab, but also mzTab could be extended to accommodate this data. In addition to output 
formats one should also keep an eye on input files and their standardisation, which includes 
mzML for peak lists (Martens et al., 2011) and PEFF for sequence databases (Binz et al., 
2019). In any case, part of integrating the needs of the crosslinking community into general 
proteomics standards will be developing parser libraries, readers and writers. Crosslinking MS 
search software should be adapted to write results and search parameters in standards 
compliant form to allow direct sharing of data, metadata and results. As crosslinking is evolving 
as a method this will also lead to evolving standards and result in a continuous need to update 
software tools. We acknowledge that the complexity of the data makes the whole process of 
changing existing software tools and also maintaining them challenging. 
Recommendation 6: Publication guidelines 
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Publication guidelines should be developed for what constitutes a sufficiently detailed 
description of experimental design (Recommendation 1), sample and data processing 
(Recommendations 2 and 4), and presentation of results (Recommendations 3 and 5).  
5.3 Knowledge transfer 
Recommendation 7: Access to Crosslinking MS results for modelling 
Efforts should be undertaken to maximise access of other researchers and communities to 
the link and interaction data obtained by Crosslinking MS. In fact, wwPDB/PDB-Dev has 
reached out in the name of the structural biology and modelling field to the Crosslinking MS 
field with the specific requirement of having access to Crosslinking MS data held in a public 
repository in standardised form and with quality descriptors. These requirements are going to 
be met by Recommendations 2 (FDR), 3 (data repository) and 5 (file formats). Once 
Crosslinking MS formats have been established, parsers can and will be written to stably link 
the data into the workflows of the modelling community and the public model repository, 
PDBdev.  
Recommendation 8: Accessibility of Crosslinking MS data to experimentalists 
Providing biological researchers with efficient access to Crosslinking MS results requires those 
data to be integrated in existing resources containing protein-protein interaction information 
such as IntAct, UniProt and STRING. This requires first of all Crosslinking MS data to make it 
into these repositories in an automated and quality-controlled way (linking to Recommendation 
2 and 3). This includes the writing of parsers that convert Crosslinking MS results into formats 
for molecular interactions and protein complexes. This also mandates the further development 
of crosslinking data visualisation tools and their integration with public databases. These 
visualisation tools can be broadly categorised by their purpose: Investigating spectral 
data,protein structure, or protein interaction networks. This does not necessarily comprise a 
definitive listing as these tools and their integration with each other and other tools is under 
active development. Even within the first category, consisting of spectral interpretations, the 
often long lists of crosslinked proteins and crosslinked amino acid residues returned by 
Crosslinking MS are not intuitively understandable to humans. The ability to display residue-
resolution information provided by Crosslinking MS has been shown to provide a more suitable 
visual data interaction platform ((Combe et al., 2015; Graham et al.; Hoopmann et al., 2015, 
2016; Keller et al., 2019b; Kolbowski et al., 2018; Riffle et al., 2016), among a subset of 
examples). Tools increase in value through integration, for example node-link diagrams that 
classically display protein interaction data (Combe et al., 2015) can be supplemented by a 
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display of the residue-level spectral interpretations (Graham et al.; Riffle et al., 2016). 
Visualisation tools should be (further) developed to allow a seamless interrogation of 
Crosslinking MS data from a wide angle of perspectives with a focus on understanding the 
data and developing testable hypotheses from it. This requires linking of the visualisation to 
the public repository of Crosslinking MS data on one side and public repositories of protein 
function and interaction data on the other side. Visualisation tools should have low entry 
barriers such as being browser-based (Combe et al., 2015; Deutsch et al., 2015; Graham et 
al.; Kolbowski et al., 2018; Riffle et al., 2016; Trnka et al., 2014) or easy to install (Kosinski et 
al., 2015), and be open source and grants funded to ensure transparent development and 
access by the widest possible number of researchers. 
5.4 Future development of Crosslinking MS 
Recommendation 9: Crosslinking MS comes in many flavours 
Crosslinking MS is currently seeing the rapid prototyping of novel workflows. These workflows 
implement different ideas around the same basic concept but use in part very different 
analytical tools. Given the diversity of approaches that exist for proteomics, it is unclear if ever 
a unified workflow will arise for Crosslinking MS (Leitner et al., 2016; O’Reilly and Rappsilber, 
2018; Sinz, 2018; Steigenberger et al., 2020; Yu and Huang, 2018). Therefore, many 
fundamental elements of the workflow should not be subject to strict standardisation at this 
point. This specifically includes (a) crosslinking reagents, as many types of crosslinking 
reagents and chemistries exist and new ones are introduced on a regular basis; (b) 
instrumentation, as many types of mass spectrometers with diverse features (e.g. 
fragmentation techniques, real-time decision making processes) exist and certainly the 
technology will continue to evolve; and (c) data analysis software, as many types of 
crosslinking analysis software exist and, again, there is a continuous development of entirely 
new software tools or new versions of existing tools. 
In addition, there are many different ways of combining chemistry, MS and bioinformatics, 
although dependencies can and do exist (e.g., a software will only work with crosslinking 
reagents of a certain design, or it may only accept certain types of MS data). Although some 
workflows may be more suitable than others for a given application, crosslinking can be 
applied in many different contexts. There is a large diversity of strategies being explored and 
will be explored for the foreseeable future. Clearly, we believe that a larger number of workflow 
designs will be fit for purpose. Note that diversity also exists in other fields, for example many 
different software tools are used successfully for protein identification in proteomics.  
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Recommendation 10: Community benchmark exercise  
The first community-wide, comparative Crosslinking MS study published in 2019 (Iacobucci et 
al., 2019) highlighted the desire of the field for transparent assessments of the many different 
workflows through organised challenges. This should be continued and expanded to include 
all application areas of Crosslinking MS from single proteins over multi-protein complexes to 
highly complex mixtures of proteins. These challenges should provide both experimentalists 
and computational scientists the opportunity to showcase and benchmark their tools and 
demonstrate the progress of the field or/and highlight remaining challenges in the respective 
areas.  
Recommendation 11: Minimal standards for the reporting of new tools 
New crosslinking reagents and new search software (versions) are frequently reported. While 
these reports typically contain proof-of-principle evidence they often lack data that allows 
assessing in full the merits of these new or changed tools. This limits not only the uptake of 
these tools but also makes it more difficult for others to plan their experiments in light of the 
many choices that are on offer. We should therefore develop guidelines and possibly 
benchmark challenges that provide the field with a general comparability of tools and ideally 
a quantitative assessment of progress. The above-mentioned organised challenges are one 
approach to this, albeit infrequent and should be supplemented by rolling or/and fixed 
challenges. Rolling challenges are known for example in protein structure modelling: 
Continuous Automated Model Evaluation (CAMEO) (Haas et al., 2018). Here an available yet 
confidential structure is used as ground truth against which submitted models are assessed. 
Especially when it comes to protein-protein interactions such a ground truth typically does not 
exist for Crosslinking MS and therefore alternative approaches for evaluation will need to be 
developed. 
 
6. Implementation 
Crowd-sourcing community standards is known to be a very time-consuming process. To 
streamline this process, we suggest that initially a small group gathered from the authors of 
this paper and any other interested party (please contact AL or JR) proposes such standards. 
Initial discussions may be performed through online discussion groups, where different 
opinions towards best practices can be shared and specific challenges discussed. Once a 
consensus emerges, recommendations would be presented at a community meeting such as 
the annual Symposium on Structural Proteomics and reported in a publication. This process 
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is to some extent reminiscent of the procedures established by the HUPO-PSI. Many of the 
different aspects of standardisation will require significant funding, for example, to develop 
new and adapt existing software, and continuous funding support to ensure standards and 
their implementation tools to evolve with the changing needs of this rapidly developing field. 
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Figure legends 
 
Figure 1. General Crosslinking MS workflow. a, Crosslinkers comprise various chemistries 
and spacer lengths. Depending on the experimental workflow used, the crosslinker spacer 
may be cleavable in the mass spectrometer (C) or isotope labeled (star), or have moieties that 
can be biochemically enriched (E) and chemically released (R). b, Concentrations and 
reaction times must be empirically tested for each application to achieve optimal amounts of 
crosslinking. c, Proteins can be digested in solution or in gel to produce a mixture of 
crosslinked and linear peptides. Also “dead-end” products, where the crosslinker has 
hydrolysed on one end, “loop-links”, where the crosslink ends up in a single peptide, and 
higher order products, comprising more than two peptides and/or more than one crosslinker 
moiety, can form. d, After digestion, crosslinked peptides are often enriched through 
chromatographic methods, such as size-exclusion chromatography, strong-cation exchange 
chromatography or affinity chromatography. e, MS/MS acquisition pipelines have been 
designed to increase the likelihood of selecting crosslinked peptide precursors for 
fragmentation. f, Various search software solutions have been developed to identify the two 
linked peptides from the spectra. g, Through methods that determine the false-discovery rate 
(FDR), the list of matches is cut to the desired confidence. h, The links are visualised and/or 
i, used as part of integrative modelling. j, The data are deposited in public repositories. Figure 
in parts adapted from (O’Reilly and Rappsilber, 2018) 
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Figure 1. 
